Responses
Section 4: Clinical pharmacy services
4CPS-006 Evaluation study of the change in administration timing of fixed combination: netupitant and palonosetron in oncohaematologic patients with high doses of carboplatin
Compose a Response to This Article
Other responses
No responses have been published for this article.